ARTICLE | Company News
Modex, Eukarion small molecule deal
October 5, 2001 7:00 AM UTC
Modex (SWX:MDXN) received a license from Eukarion (Bedford, Mass.) to a small molecule mimic of superoxide dismutase (SOD) and catalase. MDXN plans to develop the product into a topical treatment for ...